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and Health Zone. CONCLUSIONS: Age-adjusted death rates of unintentional fatal
poisonings increased for Kansas City, Missouri, from 1999 to 2008. Sex, age, annual
income, and Health Zone, were risk factors for unintentional fatal poisonings.
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OBJECTIVES: Emergency Department [ED] overcrowding is a national problem.
This study evaluates the effect of a provider/nurse triage model (Rapid Evaluation
Unit, REU) designed to improve the efficiency of the ED on ED patient volume and
ambulance diversionhours.METHODS:Data ondaily patient counts [inpatient, ED]
and ambulance diversion hours for a single hospital in Baltimore were used to
evaluate the impact of REU on hospital performance. Data covered 2008, the year
before the REU was implemented, and 2009 during which the REU was imple-
mented incrementally. The REU was operating on Monday-Wednesday from Jan-
uary 1st through March 31st, and then Monday through Friday from April 1st
through December 31st. Regression models were estimated for the daily counts for
admissions, ED visits and ambulance diversion days controlling for time trend
effects, day of the week and month of the year. A spline functional form was used
to test the effects of the REU on pre-2009 time trends and to improve model fit.
Models were adjusted for autocorrelation and heteroskedasticity as needed.
RESULTS: The REU significantly increased ED patient visit counts by 5.5 visits per
day [p0.01] without increasing the number of hours the hospital was diverting
ambulances due to over crowding [0.83 hours per day, p0.05]. For ED visits, all
months exhibited significantly higher daily ED visit counts than inDecember, rang-
ing from 9 to 28 visits per day. The early work week [Monday-Wednesday] also
exhibited significantly higher rates of ED visits than Saturday [range: 5-12 visits per
day].CONCLUSIONS:The REUwas effective at increasing ED visitswithout increas-
ing ambulance diversion hours. We theorize that this may be due to a reduction in
the time spent by patients waiting for treatment.
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OBJECTIVES:Medication reconciliation is the process of obtaining andmaintaining
a complete and accurate list of the current medication therapy of a patient across
health care setting. The combination of recorded and reported (assessed through
patient counseling) medication use may increase the accuracy of medication rec-
onciliation process. The objective of this study is to prevent drug-related problems
and evaluate the effect of pharmacist-conducted medication reconciliation with
patient counseling at hospital admission.METHODS: Patients who were admitted
to Internal Medicine in local hospital, with age over 65 years, more than two co-
morbidities and receiving more than three regular medications were recruited.
Patients with cancer, admitted to the ICU, discharged within 48 hours, or unable to
communicate were excluded. Then, these patients were interviewed by pharma-
cists within 48 hours after admission. The unintentional discrepancies were dis-
cussed with the physicians and drug therapy would be adjusted accordingly. The
primary outcome of this study included the rate of unintentional discrepancies
identified by pharmacists before and after patient counseling and the rate of un-
reconciled medications resolved by pharmacists. RESULTS: Forty-nine patients
were recruited in this study and 129 unreconciledmedicationswere found between
October 17 and November 18, 2010. The most common type of discrepancies was
omissions with rate of 58.7%. On the other hand, the rate of unintentional discrep-
ancies identified by pharmacist which may cause harm increased from 6.6% to
12.4% after patients counseling and 81.3% of drug-related problem was resolved
after pharmacist intervention. Additionally, allergy history was established in
16.3% of patients. CONCLUSIONS: Pharmacist-conducted medication reconcilia-
tion with patient counseling improved drug therapy and completeness and accu-
racy of allergy history. However, this studywas only undertaken in patients admit-
ted to Internal Medicine during one month. Implementation of medication
reconciliationwith patient counseling to further patients, such as surgical patients
may be considered.
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OBJECTIVES: The aim of the present analysis was to identify what was the influ-
ence of prices and the corresponding low cost-effectiveness estimates of the ap-
praised orphan drugs on AHTAPol recommendations. The main task of AHTAPol,
established in 2005, is to assess and appraise all medical technologies and services
claiming publicmoney founding. Pharmacoeconomic evaluations of new therapies
are required for all reimbursement decisions and orphan drugmanufacturers can-
not be exempted from providing a full pharmacoeconomic or HTA reports. Recom-
mendations issued by AHTAPol have been based onManufacturer‘s submission,
additional officially published data, experts opinions and Polish public payer
(National Health Fund) evaluation.METHODS: All recommendations issued by the
AHTAPol until the end of 2010 were reviewed and analyzed from the official Web site
ofAHTAPol. Theorphandrugs recommendationswere identifiedand categorized into
types of recommendations (positive or negative) and reasoned. RESULTS:Among 286
AHTAPol decisions studied, 26 (9%) applied to orphan drugs. AHTAPol gave positive
recommendations for reimbursement to 19 of 26 of orphan drug submissions (73%). 7
(27%) were not approved and received negative recommendations. Only in one case
cost-effectiveness estimates and the corresponding high priceswere emphasized as a
main reason of negative recommendations. In 1 case the reason was connected
with drug safety issues, while in 5 cases with insufficient evidence of efficacy.
CONCLUSIONS:Thecost-effectiveness issues of theappraisedorphandrugswerenot
important argument in negative recommendations of the AHTAPol. In fact the insuf-
ficient evidence of clinical efficacy were the most important and therefore prevailing
argument for issuing negative opinions of AHTAPol recommendations.
PHP56
DEMONSTRATING CLINICAL-EFFECTIVENESS USING INDIRECT AND MIXED
TREATMENT COMPARISON ANALYSIS: A REVIEW OF MANUFACTURERS’
SINGLE TECHNOLOGY APPRAISAL (STA) SUBMISSIONS TO THE NATIONAL
INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE)
Bending MW1, Hutton J1, McGrath C2
1University of York, York Health Economics Consortium, York, UK, 2Pfizer, Surrey, UK
OBJECTIVES: Indirect and Mixed Treatment Comparisons (ITC/MTC) can provide
valuable information for decision-makers, especially when direct comparisons be-
tween medicines are unavailable. The objective of this study is to investigate the
methods and impact of ITC and MTC submitted by manufacturers on the NICE
committee’s appraisal of pharmaceuticals. METHODS: A search of the NICE web-
site was conducted for manufacturers’ submissions that reported to contain either
an ITC orMTC since 2006. Datawere extracted and analysed for the type of network
meta-analysis, number of trials, head-to-head trial evidence available, disease
area, treatment comparisons, study selection justification, sensitivity analysis of
trial selection and outcome(s). The impact was assessed by analysing information
on Evidence Review Group (ERG) review of evidence synthesis, Appraisal commit-
tee’s comments and final decision. RESULTS: The search identified 24 submissions
that included either a MTC or ITC. The issues most frequently raised by the ERG
were lack of reporting of trial characteristics, description of methods and quality
assessment of all trials included. The most frequent validity concerns were both
clinical and statistical heterogeneity between trials, inappropriate methods of
analysis, exclusion of relevant trials and sparse numbers of trials in the network.
The committee considered all evidence and reported the analysis to be plausible on
one occasion, stated concernswith the validity in 18 appraisals and did not directly
comment on 5 occasions. Fifty eight percent of appraisals including an MTC or ITC
resulted in a restricted decision. CONCLUSIONS: ITC and MTC analysis has pro-
vided additional useful information for NICE appraisals but there has been wide
variation in the reporting and validity of analysis performed. Reimbursement
agencies should establish guidelines for the conduct of ITC andMTC to reduce this
variation. The emerging ISPOR Good Research Practice guide on indirect treatment
comparisons will provide a basis for these.
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OBJECTIVES: The objective was to understand the extent of the insurance-loss
problem in the United States over a four-year period (2004-2007) by (1) determining
the number (and proportion) of individuals who experienced loss in insurance
coverage and (2) for those who experienced gaps in coverage, determining the
average length of those periods of time when they were without coverage.
METHODS: This study was a retrospective, longitudinal data analysis using
monthly data from the 2004-05, 2005-06, and 2006-07 panels of the Medical Expen-
diture Panel Survey (MEPS). Individuals were categorized on the basis of continuity
of insurance coverage: a cohort of continuously insured individuals; a cohort of
continuously uninsured people; and a cohort of people who experienced gaps
(from one to 23 months) in coverage. The number and percent of individuals who
were in each group for each panel were calculated. A chi-square test was used to
determine if therewere differences in the distribution of health insurance patterns
between the panels, and ANOVA was used to determine if there were differences
between the average gap length over the years. RESULTS: Pooling across the three
panels, there were 157,641,235 (17.37%) individuals who experienced gaps in insur-
ance coverage, 82,826,100 (9.12%)whowere continuously uninsured for 24months,
and 616,864,391 (67.95%) who had continuous coverage over a two-year period. The
proportion of continuously uninsured rose from 8.73% in 2004-05 to 9.23% in 2006-
07. The average gap length was 8.56, 8.44, and 8.54months in 2004-05, 2005-06, and
2006-07 respectively. There were no significant differences across the panels in
either the distribution of insurance coverage patterns or between the average gap
lengths. CONCLUSIONS: Patterns in health insurance coverage have remained sta-
ble over the past several years. Examination of changing patterns of insurance
coverage will be important as health reform is introduced between now and 2014.
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